Q, L., RM, A., Y, D. V., W, d. M., T, E., C, G., . . . K, B. (2021). Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(11), 1638. https://doi.org/10.2967/jnumed.120.258871
Chicago Style (17th ed.) CitationQ, Lecocq, et al. "Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 62, no. 11 (2021): 1638. https://doi.org/10.2967/jnumed.120.258871.
MLA (9th ed.) CitationQ, Lecocq, et al. "Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 62, no. 11, 2021, p. 1638, https://doi.org/10.2967/jnumed.120.258871.